Laboratory of Applied Biochemistry, Division of Biotechnology Research and Review III, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administrations, Silver Spring, MD, 20993, USA.
Pfizer Inc., Cambridge, MA, USA.
Sci Rep. 2023 Feb 10;13(1):2441. doi: 10.1038/s41598-023-29119-5.
Pathogenesis of COVID-19 by SARS-CoV-2 resulted in a global pandemic and public health emergency in 2020. Viral infection can induce oxidative stress through reactive oxygen species (ROS). Inflammation and environmental stress are major sources of oxidative stress after infection. Micronutrients such as iron, copper, zinc, and manganese play various roles in human tissues and their imbalance in blood can impact immune responses against pathogens including SARS CoV-2. We hypothesized that alteration of free metal ions during infection and metal-catalyzed oxidation plays a critical role towards pathogenesis after infection. We analyzed convalescent and hospitalized COVID-19 patient plasma using orthogonal analytical techniques to determine redox active metal concentrations, overall protein oxidation, oxidative modifications, and protein levels via proteomics to understand the consequences of metal-induced oxidative stress in COVID-19 plasma proteins. Metal analysis using ICP-MS showed significantly greater concentrations of copper in COVID-19 plasma compared to healthy controls. We demonstrate significantly greater total protein carbonylation, other oxidative modifications, and deamidation of plasma proteins in COVID-19 plasma compared to healthy controls. Proteomics analysis showed that levels of redox active proteins including hemoglobulin were elevated in COVID-19 plasma. Molecular modeling concurred with potential interactions between iron binding proteins and SARS CoV-2 surface proteins. Overall, increased levels of redox active metals and protein oxidation indicate that oxidative stress-induced protein oxidation in COVID-19 may be a consequence of the interactions of SARS-CoV-2 proteins with host cell metal binding proteins resulting in altered cellular homeostasis.
SARS-CoV-2 引起的 COVID-19 的发病机制导致 2020 年全球大流行和公共卫生紧急事件。病毒感染可通过活性氧(ROS)诱导氧化应激。感染后,炎症和环境应激是氧化应激的主要来源。铁、铜、锌和锰等微量营养素在人体组织中发挥着各种作用,其血液中的失衡会影响包括 SARS CoV-2 在内的病原体的免疫反应。我们假设感染过程中游离金属离子的改变和金属催化的氧化在感染后的发病机制中起着关键作用。我们使用正交分析技术分析了恢复期和住院 COVID-19 患者的血浆,以确定氧化还原活性金属浓度、总蛋白氧化、氧化修饰和蛋白质水平通过蛋白质组学来了解 COVID-19 血浆蛋白中金属诱导氧化应激的后果。ICP-MS 金属分析显示 COVID-19 血浆中的铜浓度明显高于健康对照组。我们证明 COVID-19 血浆中的总蛋白羰基化、其他氧化修饰和蛋白质脱酰胺作用明显高于健康对照组。蛋白质组学分析表明,包括血红蛋白在内的氧化还原活性蛋白的水平在 COVID-19 血浆中升高。分子建模与铁结合蛋白和 SARS CoV-2 表面蛋白之间的潜在相互作用一致。总的来说,氧化还原活性金属和蛋白质氧化水平的增加表明 COVID-19 中氧化应激诱导的蛋白质氧化可能是 SARS-CoV-2 蛋白与宿主细胞金属结合蛋白相互作用导致细胞内稳态改变的结果。